DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 6BUDESONIDE
02 2DIMETHYL FUMARATE
03 1ESOMEPRAZOLE MAGNESIUM
04 6FENOFIBRIC ACID
05 1OMEPRAZOLE MAGNESIUM
01 178878
02 190379
03 190410
04 1200750
05 1200913
06 1200920
07 1201573
08 1206134
09 1206200
10 1206623
11 1206724
12 1208705
13 1209339
14 1210305
15 1210499
16 1211626
01 16No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 206623
Country : US
Patented : No
Drug : DIMETHYL FUMARATE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 210499
Country : US
Patented : No
Drug : FENOFIBRIC ACID
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 200920
Country : US
Patented : No
Drug : FENOFIBRIC ACID
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 208705
Country : US
Patented : No
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 206200
Country : US
Patented : No
Drug : ESOMEPRAZOLE MAGNESIUM
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 209339
Country : US
Patented : No
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 90410
Country : US
Patented : No
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 90379
Country : US
Patented : No
Drug : FENOFIBRIC ACID
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 211626
Country : US
Patented : No
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 206134
Country : US
Patented : No
